stoxline Quote Chart Rank Option Currency Glossary
  
(MRCC)
  0 (0%)    12-27 00:26
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2025-12-26 4:40:42 PM
Short term     
Mid term     
Targets 6-month :  7.52 1-year :  7.94
Resists First :  6.44 Second :  6.79
Pivot price 6.49
Supports First :  5.86 Second :  4.87
MAs MA(5) :  6.32 MA(20) :  6.49
MA(100) :  6.87 MA(250) :  0
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  21.5 D(3) :  29.7
RSI RSI(14): 37.4
52-week High :  8.85 Low :  5.86
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ MRCC ] has closed above bottom band by 11.4%. Bollinger Bands are 3.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 6.25 - 6.28 6.28 - 6.31
Low: 5.93 - 5.97 5.97 - 6.01
Close: 6.13 - 6.19 6.19 - 6.25
Company Description

Headline News

Fri, 26 Dec 2025
Will MRCC stock see insider buying - Institutional Holding Changes & Maximum Profit Growth - bollywoodhelpline.com

Wed, 24 Dec 2025
Monroe Capital (NASDAQ:MRCC) Stock Passes Below 200-Day Moving Average - Time to Sell? - MarketBeat

Sun, 21 Dec 2025
Trading Systems Reacting to (MRCC) Volatility - Stock Traders Daily

Tue, 16 Dec 2025
Monroe Capital Corporation (MRCC) advances SLF wind-down ahead of Horizon merger - Stock Titan

Wed, 05 Nov 2025
Monroe Capital (MRCC) Q3 Earnings and Revenues Lag Estimates - Yahoo Finance

Sun, 19 Oct 2025
ESMO 2025: Lymphocyte Activation Gene-3 (LAG3) Expression Patterns and Immunotherapy (IO) Response in Metastatic Renal Cell Carcinoma (mRCC) - UroToday

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 22 (M)
Shares Float 0 (M)
Held by Insiders 0.8 (%)
Held by Institutions 21.2 (%)
Shares Short 142 (K)
Shares Short P.Month 128 (K)
Stock Financials
EPS -0.19
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 7.98
Profit Margin -9.6 %
Operating Margin 70.6 %
Return on Assets (ttm) 4.6 %
Return on Equity (ttm) -2.3 %
Qtrly Rev. Growth -47.8 %
Gross Profit (p.s.) 2.01
Sales Per Share 2.01
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 108 (M)
Levered Free Cash Flow 9 (M)
Stock Valuations
PE Ratio -32.64
PEG Ratio 0
Price to Book value 0.77
Price to Sales 3.07
Price to Cash Flow 1.24
Stock Dividends
Dividend 0.25
Forward Dividend 0
Dividend Yield 4%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android